Spotlight on nilotinib in the treatment of chronic myelogenous leukemia
Stephen Harnicar, Sherry Mathew Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY, USA Abstract: Nowhere has targeted therapy been more successful in the hematologic malignancy arena than chronic myelogenous leukemia (CML). By targeting the BCR–ABL fusion oncoge...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-08-01
|
| Series: | Blood and Lymphatic Cancer: Targets and Therapy |
| Online Access: | http://www.dovepress.com/spotlight-on-nilotinib-in-the-treatment-of-chronic-myelogenous-leukemi-peer-reviewed-article-BLCTT |